There has been long-standing interest in the idea of polypill (a pill containing a statin and an anti-hypertensive agent) being used by healthy people, as a tool to prevent heart disease (and possibly other diseases). In a recent paper in JECH, Michael Holmes and Neeraj Bhala suggest that polypill may be used similarly as vaccines have been used for communicable diseases. This podcast presents a discussion on the polypill concept and whether the current evidence is good enough to advocate its large scale use.See also:The physiological paradox: reframing the polypill as a vaccine for cardiovascular disease http://bit.ly/1kHBD6fPopulations and polypills: if yes, then how? http://bit.ly/1g4KVTSPolypill is not a ‘vaccine-like’ solution for primary cardiovascular disease prevention in all parts of the world http://bit.ly/1g4KM2K
